The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SCLP SCANCELL HOLDINGS PLC ORD 0.1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
09:00 27-Jan-2016 SCLP Amendment to Options RNS -6.78% Down
07:00 27-Jan-2016 SCLP Half Yearly Report RNS -6.78% Down
07:00 11-Jan-2016 SCLP SCIB1 Early Immune Effect Observed by ImmunTraCkeR RNS +0.85% Up
07:00 07-Jan-2016 SCLP Directorate Change RNS +2.74% Up
07:00 05-Jan-2016 SCLP Key Moditope paper published in Cancer Research RNS -3.40% Down
07:00 18-Dec-2015 SCLP US Phase II combination study with SCIB1 RNS +26.18% Up
13:05 20-Oct-2015 SCLP Results of AGM RNS -21.95% Down
07:00 20-Oct-2015 SCLP AGM Business Update RNS -21.95% Down
07:00 14-Oct-2015 SCLP Directorate Change RNS +2.34% Up
07:00 06-Oct-2015 SCLP Six scientific presentations at PIVAC Conference RNS +0.42% Up
07:00 18-Sep-2015 SCLP Final Results for the year ended 30 April 2015 RNS -6.96% Down
07:00 16-Sep-2015 SCLP ImmunoBody presented at Cancer Vaccines Conference RNS -1.09% Down
16:42 27-Aug-2015 SCLP Notice of AGM RNS +4.32% Up
07:00 30-Jul-2015 SCLP Collaboration with ImmunID RNS -3.23% Down
07:00 09-Jul-2015 SCLP Patient recruitment completed for SCIB1 trial RNS -5.64% Down
07:00 02-Jun-2015 SCLP SCIB1 data update in resected melanoma patients RNS -1.29% Down
07:00 18-May-2015 SCLP Update on SCIB1 data at 2015 ASCO Annual Meeting RNS -1.30% Down
09:00 17-Apr-2015 SCLP Poster on Moditope to be presented at AACR RNS -3.21% Down
16:40 24-Mar-2015 SCLP Second Price Monitoring Extn RNS -4.26% Down
16:35 24-Mar-2015 SCLP Price Monitoring Extension RNS -4.26% Down

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address Department of Clinical Oncology, City Hospital, Hucknall Road, Nottingham, NG5 1PB, United Kingdom
Company website http://www.scancell.co....
Market cap(in millions)* £ 40.76
Listing/Admission to trading 30 Jul 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
06-Feb-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 30,000
SEDOL B63D331
ISIN number GB00B63D3314



SCANCELL HLDGS share news analysis (SCLP)